Printer Friendly
Dictionary, Encyclopedia and Thesaurus - The Free Dictionary
3,920,481,324 visitors served.
forum Join the Word of the Day Mailing List For webmasters
?
Dictionary/
thesaurus
Medical
dictionary
Legal
dictionary
Financial
dictionary
Acronyms
 
Idioms
Encyclopedia
Wikipedia
encyclopedia
?

sulfonylurea

   Also found in: Medical, Wikipedia 0.01 sec.
sul·fo·nyl·u·re·a  (slf-nl-y-r)
n.
Any of a group of hypoglycemic drugs, such as tolbutamide, that act on the beta cells of the pancreas to increase the secretion of insulin.
ThesaurusLegend:  Synonyms Related Words Antonyms
Noun1.sulfonylurea - antidiabetic consisting of any of several drugs that reduce the level of glucose in the blood; used to treat diabetes mellitus
antidiabetic, antidiabetic drug - a drug used to treat diabetes mellitus
tolazamide, Tolinase - a drug (trade name Tolinase) used in treating stable adult-onset diabetes mellitus
Orinase, tolbutamide - sulfonylurea; an oral antidiabetic drug (trade name Orinase) used in the treatment of adult-onset diabetes mellitus
Want to thank TFD for its existence? Tell a friend about us, add a link to this page, add the site to iGoogle, or visit the webmaster's page for free fun content.
?Page tools
Printer friendly
Cite / link 		Feedback
Add definition
Mentioned in?  References in periodicals archive?   Dictionary browser?   Full browser?
 
Insulin reactions result from an excess of insulin via an injection or an excess of an insulin-stimulating oral hypoglycemic agent, usually in the sulfonylurea class of drugs An insulin reaction is an excessively low blood sugar level (hypoglycemia), usually lower than 50 mg/dL.
Insulin Reaction - Causes, Symptoms, Treatment by peterhutch / Health, general community
2]) with type 2 diabetes that was poorly controlled on sulfonylurea, Metformin, and/or insulin therapy received D-pinitol at a dose of 20 mg per kg of body weight per day for 12 weeks, while continuing their usual medication.
D-pinitol improves glycemic control in diabetics by Gaby, Alan R. / Townsend Letter
The drug was approved by FDA on April 28, 2005, and is indicated as adjunctive therapy to improve glycemic control in patients with Type 2 diabetes mellitus who are taking metformin, a sulfonylurea, a thiazolidinedione, a combination of metformin and a sulfonylurea, or a combination of metformin and a thiazolidinedione, but have not achieved adequate glycemic control.
Byetta associated with acute pancreatitis by Adverse Event Reporting News
 
 
 
Dictionary, Thesaurus, and Translations
?

Terms of Use | Privacy policy | Feedback | Advertise with Us | Copyright © 2012 Farlex, Inc.
Disclaimer
All content on this website, including dictionary, thesaurus, literature, geography, and other reference data is for informational purposes only. This information should not be considered complete, up to date, and is not intended to be used in place of a visit, consultation, or advice of a legal, medical, or any other professional.